Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Apr;32(4):580-4.
doi: 10.2337/dc08-1748. Epub 2009 Jan 26.

Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial

Catherine L Keating  1 , John B Dixon, Marjory L Moodie, Anna Peeters, Julie Playfair, Paul E O'Brien
Affiliations
Randomized Controlled Trial

Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial

Catherine L Keating et al. Diabetes Care. 2009 Apr.

Abstract

Objective: To determine the within-trial cost-efficacy of surgical therapy relative to conventional therapy for achieving remission of recently diagnosed type 2 diabetes in class I and II obese patients.

Research design and methods: Efficacy results were derived from a 2-year randomized controlled trial. A health sector perspective was adopted, and within-trial intervention costs included gastric banding surgery, mitigation of complications, outpatient medical consultations, medical investigations, pathology, weight loss therapies, and medication. Resource use was measured based on data drawn from a trial database and patient medical records and valued based on private hospital costs and government schedules in 2006 Australian dollars (AUD). An incremental cost-effectiveness analysis was undertaken.

Results: Mean 2-year intervention costs per patient were 13,400 AUD for surgical therapy and 3,400 AUD for conventional therapy, with laparoscopic adjustable gastric band (LAGB) surgery accounting for 85% of the difference. Outpatient medical consultation costs were three times higher for surgical patients, whereas medication costs were 1.5 times higher for conventional patients. The cost differences were primarily in the first 6 months of the trial. Relative to conventional therapy, the incremental cost-effectiveness ratio for surgical therapy was 16,600 AUD per case of diabetes remitted (currency exchange: 1 AUD = 0.74 USD).

Conclusions: Surgical therapy appears to be a cost-effective option for managing type 2 diabetes in class I and II obese patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean total intervention cost over time by intervention group.
Figure 2
Figure 2
Mean medication cost per patient over time by intervention group.
See this image and copyright information in PMC

Comment in

References

    1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414: 782– 787, 2001 - PubMed
    1. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990–1998. Diabetes Care 23: 1278– 1283, 2000 - PubMed
    1. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T: Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 23: 1499– 1504, 2000 - PubMed
    1. Khan MA, St Peter JV, Breen GA, Hartley GG, Vessey JT: Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res 8: 43– 48, 2000 - PubMed
    1. Zimmet P, Shaw J, Alberti KG: Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 20: 693– 702, 2003 - PubMed

Publication types